O método Lee Silverman para reabilitação da fala na doença de Parkinson
DOI:
https://doi.org/10.34024/rnc.2011.v19.8356Palavras-chave:
Doença de Parkinson, Fala, Voz, ReabilitaçãoResumo
As alterações da fala (disfonia e disartria) frequentemente acompanham a evolução da doença de Parkinson (DP). Objetivo. Este estudo revisa o Método Lee Silverman, considerado o mais eficiente para a reabilitação das alterações da fala na DP e atualiza os avanços na sua aplicação. Método. Foi realizada uma pesquisa nas bases de dados MEDLINE, Pubmed e Bireme dos artigos indexados publicados de 1990 a 2010, com as seguintes palavras-chave: Parkinson’s disease, PD, Lee Silverman Voice Treatment, LSVT, LSVT LOUD, LSVT parkinson, voice treatment and PD, voice therapy and PD, communication and PD, dysarthria and PD, dysphonia and PD, speech disorders and PD, voice disorders and PD, hypophonia and PD, speech motor system and PD. Resultados. Na literatura, existe ampla descrição dos resultados de estudos do método Lee Silverman na DP. Os artigos encontrados evidenciam melhora da prosódia, articulação, ressonância, respiração, inteligibilidade, intensidade e qualidade da voz, assim como da deglutição e da expressividade facial. Conclusões. Para a reabilitação da fala dispõe-se de eficientes técnicas fonoaudiológicas. Contudo, conforme a literatura científica, o emprego do Método Lee Silverman é opção vantajosa, pois foi desenvolvido especificamente para a DP. Há inúmeras evidências de sua eficácia e vem sendo continuamente avaliado, ampliando sua aplicabilidade.
Downloads
Métricas
Referências
Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525-35.
Barbosa MT, Caramelli P, Maia DP, Cunningham MCQ, Guerra HL, LimaCosta MF, et al. Parkinsonism and Parkinson’s disease in the elderly: a community-based survey in Brazil (the Bambui study). Mov Disord 2006; 21:800-8. http://dx.doi.org/10.1002/mds.20806
Fox C, Halpern A, Petska J, Spielman J, Will L, Ramig L. Voice treatment (LSVT®) for individuals with Parkinson disease: new horizons. Perspectives on voice and voice disorders 2005;15:9-16.
Darley FL, Aronson AE, Brown J. Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res 1969;12:462-9.
Spencer KA, Rogers MA. Speech motor programming in hypokinetic and ataxic dysarthria. Brain 2005;94:347-66.
Ciucci MR, Ma ST, Fox C, Kane JR, Ramig LO, Schallert R. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. Behav Brain Res 2007;182:284-9. http://dx.doi.org/10.1016/j.bbr.2007.02.020
Widgruber D, Riecker A, Hertrich I, Erb M, Grodd W, Ethofer T, et al. Identification of emotional intonation evaluated by fMRI. Neuroimage 2005;24:1233-41. http://dx.doi.org/10.1016/j.neuroimage.2004.10.034
Levy YS, Gilgun-Sherki Y, Melamed E, Offen D. Therapeutic potential of neurotrophic factors in neurodegenerative diseases. BioDrugs 2005;19:97-127. http://dx.doi.org/10.2165/00063030-200519020-00003
Plowman-Prine EK, Okun MS, Sapienza CM, Shrivastav R, Fernandez HH, Foote KD, et al. Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems. NeuroRehabilitation 2009;24:131-44.
Agid Y, Graybiel AM, Ruberg M, Hirsch E, Blin J, Dubois B, et al. The efficacy of levodopa treatment declines in the course of Parkinson’s disease: do nondopaminergic lesions play a role? Adv Neurol 1990;53:83-100.
Fox CM, Morrison CE, Ramig LO, Sapir S. Current perspectivies on the Lee Silverman Voice Treatment (LSVT) for people with idiopathic Parkison’s disease. Am J Speech Lang Pathol 2002;11:111-23. http://dx.doi.org/10.1044/1058-0360(2002/012)
Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson’s disease. Lancet 2004;3:547-56. http://dx.doi.org/10.1016/S1474-4422(04)00854-3
Trail M, Fox C, Ramig L, Sapir S, Howard J, Lai EC. Speech treatment for people with Parkinson’s disease. NeuroRehabilitation 2005;20:205-21.
Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Semin Speech Lang 2006;27:283-99. http://dx.doi.org/10.1055/s-2006-955118
Sapir S, Spielman JL, Ramig LO, Story BH, Fox C. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. J Speech Lang Hear Res 2007;50:899-912. http://dx.doi.org/10.1044/1092-4388(2007/064)
Skodda S, Schlegel U. Speech rate and rhythm in Parkinson’s disease. Mov Disord 2008;23:985-92. http://dx.doi.org/10.1002/mds.21996
Ramig LO, Fox C, Sapir S. Speech treatment for Parkinson’s disease. Expert Rev Neurother 2008;8:297-309. http://dx.doi.org/10.1586/14737175.8.2.297
Narayana S, Fox PT, Zhang W, Franklin C, Robin DA, Vogel D, et al. Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis. Hum Brain Mapp 2010;31:222-36.
Liotti M, Ramig LO, Vogel D, New P, Cook CI, Inghan RJ, et al. Hypophonia in Parkinson’s disease: neural correlates of voice treatment revealed by PET. Neurology 2003;60:432-40.
Klein JA, Jones TA. Principles of experience-dependent neural plasticity: Implications for rehabilitation after brain damage. J Speech Lang Hear Res 2008;51:S225-S39. http://dx.doi.org/10.1044/1092-4388(2008/018)
Ramig L, Bonitati CM, Lemke JH, Horii Y. Voice treatment for patients with Parkinson disease: development of an approach and preliminary efficacy data. J Med SpeechLang Pathol 1994;2:191-209.
Smith M, Ramig L, Dromey C, Perez K, Samandari R. Intensive voice treatment in Parkinson’s disease: laryngostroboscopic findings. J Voice 1995;9:453-9. http://dx.doi.org/10.1016/S0892-1997(05)80210-3
Ramig LO, Countryman S, Thompson L. Efficacy of voice therapy for patientes with Parkinson’s disease. J Speech Hear Res 1995;97:164-72.
Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal following intensive voice treatment (LSVT®) in individuals with Parkinson’s disease: a comparison with untreated patientes and normal age-matched controls. Mov Disord 2001;16:79-93. http://dx.doi.org/10.1002/1531-8257(200101)16:1<79::AIDMDS1013>3.0.CO;2-H
Dias AE, Limongi JCP. Treatment of vocal symptoms in Parkinson’s disease: the Lee Silverman method. Arq Neuropsiquiatr 2003;61:61-6. http://dx.doi.org/10.1590/S0004-282X2003000100011
Ramig L, Countryman S, Thompson L, Horii Y. A comparison of two forms of intensive speech treatment for Parkinson disease. J Speech and Hear Res 1995;38:1232-51.
Ramig LO, Countryman S, O’Brien C, Hoehn M, Thompson L. Intensive speech treatment for patients with Parkinson’s disease: short and long-term comparison of two techniques. Neurology 1996;47:1496-504.
Baumgartner C, Sapir S, Ramig L. Voice quality changes following phonatory- respiratory effort Treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease. J Voice 2001;15:105-14. http://dx.doi.org/10.1016/S0892-1997(01)00010-8
Sapir S, Ramig L, Hoyt P, O’Brien C, Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson’s disease: a comparison with an alternative speech treatment. Folia Phoniatr 2002;54:296-303. http://dx.doi.org/10.1159/000066148
Ramig LO, Sapir S, Countryman S, Pawlas AA, O’Brien C, Hoehn M, et al. Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: a 2 year follow up. J Neurol Neurosurg Psychiatry 2001;71:493-98. http://dx.doi.org/10.1136/jnnp.71.4.493
Yorkston KM, Spencer KA, Duffy JR. Behavioral management of respiratory/phonatory dysfunction from dysarthria: a systematic review of the evidence (ANCDS Bulletin Board). J Med Speech Lang Pathol 2003;11 (2):xxxix-lxi.
Spielman JL, Borod JC, Ramig LO. The effects of intensive voice treatment on facial expressiveness in Parkinson disease: preliminary data. Cogn Behav Neurol 2003;16:177-88. http://dx.doi.org/10.1097/00146965200309000-00005
Sapir S, Spielman J, Ramig L, Story B, Fox C. Effects of intensive voice treatment (LSVT) on vowel articulation in dysarthric individuals with idiopathic Parkinson’s disease: Acoustic and perceptual findings. J Speech Lang Hear Res 2007;50:899-912. http://dx.doi.org/10.1044/1092-4388(2007/064)
El Sharkawi A, Ramig LO, Logemann JA, Pauloski BR, Rademaker AW, Smith CH, et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): A pilot study. J Neurol Neurosurg Psychiatry 2002;71:31-6.
Sapir S, Ramig L, Fox C. Speech and swallowing disorders in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg 2008;16:205-10. http://dx.doi.org/10.1097/MOO.0b013e3282febd3a
Liotti M, Ramig LO, Vogel D, New P, Cook CI, Ingham RJ, et al. Hypo-phonia in Parkinson’s disease: neural correlates of voice treatment revealed by PET. Neurology 2003;60:432-40.
Narayana S, Fox PT, Zhang W, Franklin C, Robin DA, Vogel D, et al. Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis. Hum Brain Mapp 2010;31:222-36.
Dias AE. Reabilitação em grupo das disartrofonias em doentes de Parkinson pelo método Lee Silverman (Dissertação). São Paulo: Faculdade de Medicina da Universidade de São Paulo, 2003, 100p.
Halpern A, Matos C, Ramig L, Petska J, Spielman J, Bennett J. LSVTC: A PDA supported speech treatment for Parkinson’s disease. Presented at the Annual 9th International Congress of Parkinson’s Disease and Movement Disorders, New Orleans, 2005;20(10): S134.
Kamińska, I, Zebryk-Stopa A, Pruszewicz A, Dziubalska-Kolaczyk K, Polczyńska-Fiszer M, Pietrala D, et al. The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment). Otolaryngol Pol 2007;61:713-8.
Spielman J, Ramig LO, Mahler L, Halpern A, Gavin WJ. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson’s disease. Am J Speech Lang Pathol 2007;16:95-107. http://dx.doi.org/10.1044/1058-0360(2007/014)
Tindall R, Huebner RA, Stemple JC, Kleinert HL. Videophone-delivered voice therapy: a comparative analysis of outcomes to traditional delivery for adults with Parkinson’s disease. Telemed J E Health 2008;14:1070-7. http://dx.doi.org/10.1089/tmj.2008.0040
Howell S, Tripoliti E, Pring T. Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study. Int J Lang Commun Disord 2009;44:287-300. http://dx.doi.org/10.1080/13682820802033968
Constantinescu GA, Theodoros DG, Russel TG, Ward EC, Wilson SJ, Wooton R. Home-based speech treatment for Parkinson’s disease delivered remotely: a case report. J Telemed Telecare 2010;16:100-4. http://dx.doi.org/10.1258/jtt.2009.090306
Dias AE, Limongi JCP, Barbosa ER. The Lee Silverman Voice Treatment method in the rehabilitation of hypophonia in Parkinson’s disease: new perspective. Presented at the 14th International Congress of Parkinson’s Disease and Movement Disorders, Buenos Aires, 2010;11:LB-29.
Downloads
Publicado
Como Citar
Edição
Seção
Publicado: 2011-09-30
Português
English
Español
